NeuroPace, Inc.
NPCE
$14.09
-$0.03-0.21%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -2.73M | -3.50M | -8.65M | -6.59M | -5.25M |
| Total Depreciation and Amortization | 522.00K | 487.00K | 477.00K | 462.00K | 451.00K |
| Total Amortization of Deferred Charges | 63.00K | 70.00K | 55.00K | 49.00K | 49.00K |
| Total Other Non-Cash Items | 2.71M | 2.67M | 3.94M | 2.97M | 2.96M |
| Change in Net Operating Assets | -63.00K | -1.67M | 2.09M | -4.37M | -3.00M |
| Cash from Operations | 506.00K | -1.94M | -2.09M | -7.48M | -4.80M |
| Capital Expenditure | -97.00K | -30.00K | -168.00K | -37.00K | -39.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | 2.00M |
| Cash from Investing | -97.00K | -30.00K | -168.00K | -37.00K | 1.96M |
| Total Debt Issued | 0.00 | -133.00K | 58.57M | -- | -- |
| Total Debt Repaid | 0.00 | 0.00 | -60.51M | -- | -- |
| Issuance of Common Stock | 723.00K | -- | 205.00K | 70.88M | 940.00K |
| Repurchase of Common Stock | -88.00K | -102.00K | -174.00K | -49.77M | -92.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 635.00K | -235.00K | -1.91M | 21.11M | 848.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.04M | -2.21M | -4.16M | 13.59M | -1.99M |